Clinical Trial Update: LEO 32731 - A Phase I Study in Healthy Subjects [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase I study of LEO 32731 in healthy subjects, with psoriasis vulgaris listed as the study condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• LEO 32731

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 1 | Status: COMPLETED